Absolute quantitative proteomics guides patient-stratified drug repurposing in clear cell and papillary renal cell carcinoma.
André Q. Figueiredo, Inês F. Domingos, Carlos Lodeiro, Rajiv Dhir, Luís B. Carvalho, Laura Mercolini, Jacek R. Wiśniewski, Gianluca Moroncini, Mariana Silva Medeiros, Luís Campos Pinheiro, Hélder Mansinho, Hugo Miguel Santos, Dimitrios K. Korentzelos, José Luís Capelo
This paper uses absolute quantitative proteomics to identify patient-specific drug repurposing strategies for clear cell and papillary renal cell carcinoma.
bioRxiv · Jul 17, 2026 · PreprintBiochemistry